Top 23 GTx investors
The most complete profiles first. Showing 23 of 23.
Ken HaasVerified
Venture Capital, Advisor, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Sunny ReddyVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Verified email available
andrew sinclairVerified
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Aftab KheraniVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Verified email available
Andrew SchiffVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 60 more
Verified email available
Eric AguiarVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Verified email available
Gary StevensonVerified
Venture Capital, Micro VC · United States
Health CareWomen FoundedMobileManufacturingPortfolio: HandMinder, Spine Wave, Restore Medical Solutions, Alveolus and 42 more
Verified email available
Josh BilenkerVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Verified email available
Robert WenzelVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Verified email available
Shelley ChuVerified
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Tim HainesVerified
Venture Capital · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Bali Muralidhar
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 69 more
Contact details available
Brian Gallagher, Jr.
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Aileron Therapeutics, Amarin and 67 more
Contact details available
Kurt von Emster
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareWomen FoundedInvestment ManagementLife SciencePortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Vin Miles
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
John Heard
Venture Capital, Private Equity Firm · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Norman Zhou
Venture Capital · United States
Health CareWomen FoundedLife ScienceInformation Technology (IT)Portfolio: Black Diamond Therapeutics, AveXis, Aligos Therapeutics, Tyra Biosciences and 46 more
Contact details available
Sarah Shackelton
Venture Capital · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Scott Braunstein
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Contact details available
Sophie Phillips
Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Contact details available
Andres BethencourtVerified
Venture Capital, Private Equity Firm · United States
Health CareGeneticsE-commerceWomen FoundedPortfolio: Inspire Medical Systems, Marbles: The Brain Store, GTx, KEW Group and 1 more
Contact details available
Chris WoodburnVerified
Venture Capital · United States
Health CareGeneticsE-commerceWomen FoundedPortfolio: Inspire Medical Systems, Marbles: The Brain Store, GTx, KEW Group and 1 more
Verified email available
Eduardo ArguelloVerified
Venture Capital · United States
Health CareGeneticsE-commerceWomen FoundedPortfolio: Inspire Medical Systems, Marbles: The Brain Store, GTx, KEW Group and 1 more
Verified email available
By investment stage
By location
Related industries
Most-backed portfolio companies
- Cytos18
- Paratek Pharmaceuticals18
- Verona Pharma18
- Reneo Pharmaceuticals18
- Spruce Biosciences18
- Scorpion Therapeutics11
- Avillion10
- Pathwork Diagnostics10
- Lombard Medical plc10
- Attenua10
- Sientra10
Frequently asked questions
How many GTx investors are on Angel Roster?
Angel Roster lists 23 GTx investors. 13 of them (57%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (22), Private Equity Firms (13) and Micro VC Firms (1). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do GTx investors invest in?
Among those that list a stage, the most common are Series B (6) and Seed (1).
Where are GTx investors based?
Most are based in the United States (18) and the United Kingdom (5).
Which companies have GTx investors backed?
The most-backed portfolio companies among them are Cytos (18), Paratek Pharmaceuticals (18), Verona Pharma (18), Reneo Pharmaceuticals (18) and Spruce Biosciences (18).
How do I contact GTx investors?
Create a free Angel Roster account to search and filter all 23, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.